ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:34 am Purchase |
2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
ADAGE CAPITAL PARTNERS GP LLC | 2,775,976 6.440% |
949,162 (+51.96%) |
Filing |
| 2024-02-07 08:01 am Purchase |
2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
ADAGE CAPITAL PARTNERS GP LLC | 1,826,814 5.990% |
499,814 (+37.66%) |
Filing |
| 2023-10-12 4:30 pm Purchase |
2023-10-02 | 13G | Soleno Therapeutics, Inc. SLNO |
ADAGE CAPITAL PARTNERS GP LLC | 1,327,000 8.690% |
1,327,000 (New Position) |
Filing |